Recent studies have demonstrated that secreted frizzled-related protein 4 (SFRP4) is a potential biomarker for β-cell dysfunction in type II diabetes, associated with reduced insulin secretion (Bukhari et al., 2019; Zhang et al., 2020). Here, INS is linked to type 2 diabetes mellitus.